With the appeal deadline past and trading suspended as of July 16, 2026, PTNM shares face immediate near-total liquidity loss as they transition to the OTC market. Traders should expect minimal trading volume and significant price declines. Monitor for any potential reverse stock split or relisting plan, but the path back to Nasdaq appears extremely challenging given the SEC suspension context.
Price Chart
Executive Summary
Pitanium Limited received a Nasdaq delisting determination letter dated July 7, 2026, based on Nasdaq's discretionary authority following an SEC trading suspension in October 2025 due to potential social-media-driven manipulation. Unless appealed by July 14, trading will be suspended on July 16, 2026, and the company's securities will be removed from Nasdaq, potentially moving to the OTC market with no guarantee of liquidity.
Key Facts
- Nasdaq delisting determination letter received July 7, 2026; announced July 10, 2026, via press release furnished as Exhibit 99.1.
- SEC trading suspension ordered October 3, 2025, due to potential manipulation through social media recommendations by unknown persons.
- Appeal deadline for the delisting was July 14, 2026 — filing made on July 16, 2026, indicating appeal was not submitted (or determination not overturned).
- Trading suspended at the opening of business on July 16, 2026, and Nasdaq will file a Form 25-NSE to remove securities from listing and registration.
- No finding that the company engaged in wrongdoing — the delisting is based on Nasdaq's discretionary authority under Rule IM-5101-4 for third-party misconduct risk.
- Securities may become eligible for OTC trading, but no assurance of an active or liquid market.
- Cross-filing context includes a 20-F annual report from January 30, 2026, providing historical financials, but no financial figures from that report are cited in this filing.
Financial Impact
Loss of Nasdaq listing severely impairs liquidity and access to public equity markets; OTC trading typically results in significantly lower volumes and reduced valuation. No specific dollar figures provided in filing.
Risk Factors
- Complete loss of Nasdaq listing — shares move to OTC with severely reduced liquidity and institutional interest.
- No active or sustained trading market may develop on OTC markets, making it difficult for existing shareholders to exit positions.
- SEC trading suspension remains in place, creating regulatory overhang and limiting any potential appeal to Nasdaq.
- Company has not announced any plan to address the delisting or restore compliance.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001493152-26-033631 |
| Exhibit: ex99-1.htm | 0001493152-26-033631 |
| Document: 0001493152-26-033631-index-headers.html | 0001493152-26-033631 |
| Document: 0001493152-26-033631-index.html | 0001493152-26-033631 |
| Document: 0001493152-26-033631.txt | 0001493152-26-033631 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 17, 2026 11w ago | 6-K | $10.39 $10.39 | · 0.00% | ▼ −0.59% | — |
Jul 10, 2026 12w ago | Press Release | $10.39 $10.39 | · 0.00% | ▼ −0.94% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access